Clinical updates for biopharma and med tech, including data readouts and publications: Bioversys, Can-Fite, Cerevasc, Citius,Clearmind, Kyowa Kirin, Relief, Tensive.

Biopharma and med-tech companies raising money in public or private financings, including: Aim Immunotech, Blackstone, Persevere, Sernova, Teva.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acadia, Asieris, Atara,Dxcover, Hua, Johnson & Johnson, Meiji Seika, Northsea,Pathai, Pharmaessentia, Pierre Fabre , Priovant, Recovryai, Splisense.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Adial, Celltype, Cirna, Congruence, Corstasis, Curie.Bio, Esperion, Forendos, Hepion, Kdventures, Molteni, Ono, Organon, Secarna, Senhwa, Sinopia.

Clinical updates for biopharma and med tech, including data readouts and publications: Bioaffinity, Biocardia, Chiesi, Cour, Delcath, Ensysce, Quell, Snipr, Theravance.

Biopharma and med-tech companies raising money in public or private financings, including: Antiverse, Beken, Informuta, Maia, Modular, Poplar, Prolium, Xsensio.

New hires and promotions in the biopharma and med-tech industries, including: 4basebio, Babson, Beacon, Dimerx, Kivu, Latigo, Medivir, Protego, Seres.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbott, Agios, Ascendis, Biomarin, Innocare, Innovent, Intellia, Merck, Novo Nordisk, Protagonist, Sanofi, Scibase, Takeda, Uniqure.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Bioatla, Blueprint, Celyn, Cullgen, Deephealth, Disc, Gyre, Kairos, Medimaps, Opgen, Pulmatrix, Radiobiotics.